| Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization TB Dahl, A Yndestad, M Skjelland, E Øie, A Dahl, A Michelsen, ... Circulation 115 (8), 972-980, 2007 | 815 | 2007 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 747 | 2021 |
| Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 JW Haukeland, JK Damås, Z Konopski, EM Løberg, T Haaland, I Goverud, ... Journal of hepatology 44 (6), 1167-1174, 2006 | 710 | 2006 |
| Systemic inflammation in heart failure–the whys and wherefores A Yndestad, J Kristian Damås, E Øie, T Ueland, L Gullestad, P Aukrust Heart failure reviews 11, 83-92, 2006 | 403 | 2006 |
| Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a … O Kleveland, G Kunszt, M Bratlie, T Ueland, K Broch, E Holte, ... European heart journal 37 (30), 2406-2413, 2016 | 339 | 2016 |
| Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality–a prospective study of patients admitted with infection to the emergency department Å Askim, F Moser, LT Gustad, H Stene, M Gundersen, BO Åsvold, J Dale, ... Scandinavian journal of trauma, resuscitation and emergency medicine 25, 1-9, 2017 | 312 | 2017 |
| Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release EO Samstad, N Niyonzima, S Nymo, MH Aune, L Ryan, SS Bakke, ... The Journal of Immunology 192 (6), 2837-2845, 2014 | 285 | 2014 |
| Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization WJ Sandberg, A Yndestad, E Øie, C Smith, T Ueland, O Ovchinnikova, ... Arteriosclerosis, thrombosis, and vascular biology 26 (4), 857-863, 2006 | 265 | 2006 |
| Myocardial expression of CC-and CXC-chemokines and their receptors in human end-stage heart failure JK Damås, HG Eiken, E Øie, V Bjerkeli, A Yndestad, T Ueland, ... Cardiovascular research 47 (4), 778-787, 2000 | 265 | 2000 |
| Chemokines and cardiovascular risk P Aukrust, B Halvorsen, A Yndestad, T Ueland, E Øie, K Otterdal, ... Arteriosclerosis, thrombosis, and vascular biology 28 (11), 1909-1919, 2008 | 264 | 2008 |
| Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study TML Eagan, T Ueland, PD Wagner, JA Hardie, TE Mollnes, JK Damås, ... European respiratory journal 35 (3), 540-548, 2010 | 256 | 2010 |
| Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome M Trøseid, KT Lappegård, T Claudi, JK Damås, L Mørkrid, R Brendberg, ... European heart journal 25 (4), 349-355, 2004 | 250 | 2004 |
| Role of inflammation in the progression of heart failure A Yndestad, JK Damås, E Øie, T Ueland, L Gullestad, P Aukrust Current cardiology reports 9 (3), 236-241, 2007 | 242 | 2007 |
| Inflammatory and anti‐inflammatory cytokines in chronic heart failure: potential therapeutic implications P Aukrust, L Gullestad, T Ueland, JK Damås, A Yndestad Annals of medicine 37 (2), 74-85, 2005 | 233 | 2005 |
| Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction K Broch, AK Anstensrud, S Woxholt, K Sharma, IM Tøllefsen, B Bendz, ... Journal of the American College of Cardiology 77 (15), 1845-1855, 2021 | 224 | 2021 |
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction S Ørn, C Manhenke, T Ueland, JK Damås, TE Mollnes, T Edvardsen, ... European heart journal 30 (10), 1180-1186, 2009 | 211 | 2009 |
| Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes P Aukrust, RK Berge, T Ueland, E Aaser, JK Damås, L Wikeby, A Brunsvig, ... Journal of the American College of Cardiology 37 (2), 485-491, 2001 | 209 | 2001 |
| Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors T Wæhre, A Yndestad, C Smith, T Haug, SH Tunheim, L Gullestad, ... Circulation 109 (16), 1966-1972, 2004 | 208 | 2004 |
| CXC-chemokines, a new group of cytokines in congestive heart failure—possible role of platelets and monocytes JK Damås, L Gullestad, T Ueland, NO Solum, S Simonsen, SS Frøland, ... Cardiovascular research 45 (2), 428-436, 2000 | 204 | 2000 |
| Elevated levels of activin A in heart failure: potential role in myocardial remodeling A Yndestad, T Ueland, E Øie, G Florholmen, B Halvorsen, H Attramadal, ... Circulation 109 (11), 1379-1385, 2004 | 203 | 2004 |
